What is the recommended dose of cefepime for the treatment of acute bacterial meningitis in adults and pediatric patients according to Infectious Diseases Society of America (IDSA) guidelines?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cefepime Dosing for Acute Bacterial Meningitis

IDSA Guidelines Do Not Specifically Recommend Cefepime for Bacterial Meningitis

The IDSA guidelines and current standard-of-care protocols recommend ceftriaxone or cefotaxime as the preferred third-generation cephalosporins for bacterial meningitis, not cefepime (a fourth-generation cephalosporin). 1, 2

Standard Empiric Therapy According to Guidelines

Adults <60 Years

  • Ceftriaxone 2 grams IV every 12 hours (total 4 grams daily) is the recommended empiric therapy 1, 2
  • Alternative: Cefotaxime 2 grams IV every 6 hours 2
  • Add vancomycin 15-20 mg/kg IV every 12 hours if penicillin-resistant pneumococci are suspected 2

Adults ≥60 Years

  • Ceftriaxone 2 grams IV every 12 hours PLUS amoxicillin 2 grams IV every 4 hours to cover Listeria monocytogenes 1, 2
  • Add vancomycin if resistant pneumococci are suspected 2

Pediatric Patients

  • Ceftriaxone 50 mg/kg IV every 12 hours (maximum 4 grams daily) 1
  • For neonates 22-60 days: Ceftriaxone 50 mg/kg once daily for bacteremia/UTI, but use ampicillin plus ceftazidime for meningitis 1

Why Cefepime Is Not Standard for Meningitis

While cefepime has been studied in pediatric bacterial meningitis with comparable efficacy to cefotaxime (75% cure rate vs 78% with comparators), it is not included in current IDSA or UK Joint Specialist Societies guidelines as a first-line agent 3, 4. The guidelines consistently recommend third-generation cephalosporins (ceftriaxone/cefotaxime) over fourth-generation agents for this indication 5, 1, 2.

If Cefepime Were to Be Used (Based on Research Data)

Should clinical circumstances require cefepime use, the research-supported dosing would be:

Pediatric Dosing

  • 50 mg/kg/dose IV every 8 hours for children 2 months to 14 years 3, 4
  • This achieved CSF concentrations 55-95 times greater than the MIC of causative pathogens 4
  • Clinical cure rates of 75% and bacterial eradication rates of 92-97% depending on pathogen 3

Adult Dosing (Extrapolated)

  • No specific adult dosing for meningitis is established in guidelines
  • Standard severe infection dosing would be 2 grams IV every 8 hours, but this is not guideline-supported for meningitis

Treatment Duration by Pathogen

  • Pneumococcal meningitis: 10-14 days (longer if delayed response or resistance) 6
  • Meningococcal meningitis: 5-7 days 6
  • Haemophilus influenzae: 10 days 6
  • Listeria monocytogenes: 21 days 6
  • Enterobacteriaceae: 21 days 6

Critical Clinical Pitfall

Do not substitute cefepime for ceftriaxone/cefotaxime in bacterial meningitis without compelling clinical justification. The overwhelming guideline consensus supports third-generation cephalosporins as the standard of care, with decades of clinical experience and superior guideline support 5, 1, 2. If cefepime must be used due to drug shortages or specific resistance patterns, infectious disease consultation is strongly advised.

References

Guideline

Ceftriaxone Dosing Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Streptococcus pneumoniae Meningitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Cefepime in the empiric treatment of meningitis in children.

The Pediatric infectious disease journal, 2001

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Antibiotic Duration for Bacterial Meningitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.